Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys: 457 trades; $10.3T in total
Open-market sales: 848 trades; $1.1B in total
Insiders filing: 403 insiders; Last 7 days
Companies with several buyers: 28; Last 7 days

Tenax Therapeutics TENX

		Trade type
Chief Medical Officer	Tenax TherapeuticsTENX	Open-market buy	25/12/08–25/12/09	25/12/10	5,000 sh2 trades	$10.16avg.	$50,800	No record
Chief Medical Officer	Tenax TherapeuticsTENX	Open-market buy	25/12/02–25/12/04	25/12/05	5,000 sh3 trades	$9.13avg.	$45,630	No record
CEO	Tenax TherapeuticsTENX	Open-market buy	25/11/18–25/11/20	25/11/20	2,605 sh3 trades	$7.68avg.	$19,993.47	No record
Director	Tenax TherapeuticsTENX	Open-market buyAmendment	25/11/17–25/11/18	25/11/20	1,993 sh2 trades	$7.50avg.	$14,952.95	No record
Director	Tenax TherapeuticsTENX	Open-market buy	25/11/17–25/11/18	25/11/19	1,993 sh2 trades	$7.50avg.	$14,952.95	No record
Interim CFO	Tenax TherapeuticsTENX	Open-market buy	25/11/17	25/11/19	8,000 sh3 trades	$7.27avg.	$58,180	No record
Gerald T. ProehlDirector	Tenax TherapeuticsTENX	Open-market buy	24/08/08	24/08/08	1,666 sh	In footnote	No stated value	+166600.0%
Michael H. DavidsonDirector	Tenax TherapeuticsTENX	Open-market buy	24/08/08	24/08/08	2,500 sh	In footnote	No stated value	+656.2%